(Q3 Un-audited): As per life revenue account of the company for July to September, 2026, excess of total expenses including claims over total income (deficit) was BDT 42.39 million as against excess of total income over total expenses including claims (surplus) of BDT 4.93 million in the corresponding previous period of 2025. Whereas as per life revenue account of the company for January to September, 2026, excess of total expenses including claims over total income (deficit) was BDT 127.43 million as against excess of total expenses including claims over total income (deficit) of BDT 140.79 million in the corresponding previous period of 2025. Accordingly, Balance of Life Insurance Fund was BDT (3,320.56) million as on September 30, 2026 as against BDT (3,065.20) million as on September 30, 2025.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2026 at 2:30 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended September 30, 2026.

(Q2 Un-audited): As per life revenue account of the company for April to June, 2026, excess of total expenses including claims over total income (deficit) was BDT 35.66 million as against excess of total expenses including claims over total income (deficit) of BDT 65.32 million in the corresponding previous period of 2025. Whereas as per life revenue account of the company for January to June, 2026, excess of total expenses including claims over total income (deficit) (Continuation news of PADMALIFE): was BDT 85.10 million as against excess of total expenses including claims over total income (deficit) of BDT 150.92 million in the corresponding previous period of 2025. Accordingly, Balance of Life Insurance Fund was BDT (3,272.04) million as on June 30, 2026 as against BDT (3,077.14) million as on June 30, 2025.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on August 27, 2026 at 2:30 pm to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended June 30, 2026.

Trading of the shares of the company will resume on 09-Aug-2026.

Trading of the shares of the company will remain suspended on record date i.e., 06-Aug-2026.

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 02.08.2026 to 04.08.2026 and trading of the shares will remain suspended on record date i.e., 06.08.2026.

The auditor of the company has given the Qualified Opinion paragraph in the auditor's report for the year ended December 31, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/PADMALIFE-2025.pdf

(Q1 Un-audited): As per life revenue account of the company, total income was Tk. 51,697,375 for January to March 2026 as against Tk. 23,290,078 for January to March 2025; total expenses was Tk. 94,939,790 for January to March 2026 as against Tk. 115,883,888 for January to March 2025. Balance of Life Insurance Fund was Tk. (3,236,375,268) as on March 31, 2026 as against Tk. (3,193,132,853) as on December 31, 2025.

The Board of Directors has recommended No dividend for the year ended December 31, 2025. Date of AGM: 17.09.2026, Time: 11:00 AM, Venue: Physical presence at Padma Life Tower, (Top Floor) 115, Kazi Nazrul Islam Avenue, Banglamotor, Dhaka -1000. Record Date: 06.08.2026.